Cost effective green synthesis of NiO nanostructures as highly efficient photocatalysts for degradation of organic dyes

Micro & nano letters

article

Hameed Ullah¹  Lubna Mushtaq¹  Zia Ullah¹  Masroor Ahmad Bangesh¹  Mohsan Nawaz¹ 

[1] Department of Chemistry, Hazara University

关键词: photochemistry;    nickel compounds;    nanorods;    X-ray diffraction;    nanoparticles;    scanning electron microscopy;    crystallites;    nanofabrication;    dyes;    catalysis;    transmission electron microscopy;    Fourier transform infrared spectra;    energy gap;    organic dyes;    nickel oxide nanostructures;    reducing agents;    potatoes;    cauliflower;    peas peels;    potato peels;    x-ray diffraction analyses;    vegetable waste;    diffuse reflectance spectra analyses;    Methylene blue degradation;    photocatalysts;    organic capping agents;    NiO nanostructures;    Fourier transform infrared analysis;    nanorods;    scanning electron microscopy;    nanocrystalline cubic phase;    crystallite size;    NiO;   

DOI  :  10.1049/mnl.2018.5106

学科分类：计算机科学（综合）

来源: Wiley

【 摘 要 】

Rheumatoid arthritis (RA) is a common inflammatory disease that associated with increased morbidity and mortality due to accelerated atherosclerosis. Rosuvastatin is a unique hydroxy methyl glutaryl Co A (HMGCoA) reductase inhibitor that has anti inflammatory effects. The aim of this study was to evaluate the effect of rosuvastatin as adjuvant therapy to methotrexate (MTX) on lipid profile and its possible cardioprotective effect in RA patients. A double blinded placebo controlled clinical trial with 8 weeks follow up periods at which 40 patients with active RA using MTX were randomized into 2 groups to receive either rosuvastatin 10mg or placebo as adjuvant therapy to MTX. In addition to twenty healthy subjects as control group.  Lipid profile and erythrocyte sedimentation rate (ESR) was assessed at the start and at the end of the study. At the start of the study total cholesterol (TC), low density lipoprotein cholesterol (LDLc) and high density lipoprotein cholesterol (HDLc) values were not significantly different between RA patients and control group. At the end of the study rosuvastatin significantly reduced ESR, TC and LDLc after 8 weeks of treatment. It can be concluded that MTX has the ability to normalize lipid profile in RA patients. Rosuvastatin effectively reduce ESR, TC and LDLc; Moreover, Rosuvastatin might have a possible cardioprotective effect in RA patients.

【 授权许可】

CC BY|CC BY-ND|CC BY-NC|CC BY-NC-ND